Journal
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56
Volume 56, Issue -, Pages 323-338Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev-pharmtox-010715-103644
Keywords
chimeric mice; drug metabolism; predictive toxicology; liver humanization
Categories
Funding
- NICHD NIH HHS [1R01HD070795-01A1] Funding Source: Medline
- NIDDK NIH HHS [1R01DK0909921] Funding Source: Medline
Ask authors/readers for more resources
Most of what we know about a drug prior to human clinical studies is derived from animal testing. Because animals and humans have substantial differences in their physiology and in their drug metabolism pathways, we do not know very much about the pharmacokinetic and pharmacodynamic behavior of a drug in humans until after it is administered to many people. Hence, drug-induced liver injury has become a significant public health problem, and we have a very inefficient drug development process with a high failure rate. Because the human liver is at the heart of these problems, chimeric mice with humanized livers could be used to address these issues. We examine recent evidence indicating that drug testing in chimeric mice could provide better information about a drug's metabolism, disposition, and toxicity (i.e., its behavior) in humans and could aid in developing personalized medicine strategies, which would improve drug efficacy and safety.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available